RE49936 | Beta-hexosyl-transferases and uses thereof | Dec 18, 20 | Apr 23, 24 | North Carolina State University |
RE49736 | Pegylated L-asparaginase | Mar 18, 20 | Nov 28, 23 | Jazz Pharmaceuticals II SAS |
RE49708 | Nucleic acid molecules encoding indoleamine 2,3-dioxygenase-2 | Jan 08, 21 | Oct 24, 23 | Lankenau Institute for Medical Research |
RE49583 | Inducible expression systems | Feb 03, 21 | Jul 18, 23 | TET Systems GmbH & Co. KG |
RE49431 | RNA interference agents for GST-PI gene modulation | Aug 11, 20 | Feb 28, 23 | Nitto Denko Corporation |
RE49423 | DNA plasmids with improved expression | Dec 04, 20 | Feb 21, 23 | Nature Technology Corporation |
RE49347 | Mammalian expression vector | Aug 23, 18 | Dec 27, 22 | Novartis AG |
RE49311 | RTI545 compositions and methods of use for benefiting plant growth and controlling plant pests | Jan 22, 20 | Nov 29, 22 | FMC Corporation |
RE49293 | Cell culture methods and devices utilizing gas permeable materials | Jun 12, 18 | Nov 15, 22 | Wilson Wolf Manufacturing Corporation |
RE49294 | DNA vector production system | Mar 05, 20 | Nov 15, 22 | Mediphage Bioceuticals, Inc. |
RE49280 | TGFbeta type II-type III receptor fusions | Apr 04, 19 | Nov 08, 22 | 501 Board of Regents The University of Texas System |
RE49281 | Wnt pathway stimulation in reprogramming somatic cells with nuclear reprogramming factors | Dec 13, 19 | Nov 08, 22 | Whitehead Institute for Biomedical Research |
RE49233 | Ionizable cationic lipid for RNA delivery | Mar 12, 19 | Oct 04, 22 | Arcturus Therapeutics, Inc. |
RE49229 | Methods and compositions for treating malignant tumors associated with KRAS mutation | Feb 28, 20 | Oct 04, 22 | Nitto Denko Corporation |
RE49121 | Genetically modified mouse with an inducible ACVR1 gene with a mutant R206H exon 5 that has ectopic bone formation | Nov 13, 18 | Jul 05, 22 | Regeneron Pharmaceuticals, Inc. |
RE48960 | Antisense oligonucleotides for inducing exon skipping and methods of use thereof | Dec 19, 19 | Mar 08, 22 | THE UNIVERSITY OF WESTERN AUSTRALIA |
RE48908 | DNA vector production system | Oct 30, 19 | Feb 01, 22 | Mediphage Bioceuticals, Inc. |
RE48887 | RNA interference compositions and methods for malignant tumors | Sep 19, 19 | Jan 11, 22 | Nitto Denko Corporation |
RE48863 | toxin and methods thereof | Apr 18, 19 | Dec 28, 21 | Wyeth LLC |
RE48862 | toxin and methods thereof | Apr 18, 19 | Dec 28, 21 | Wyeth LLC |